Clinical Trials Directory

Trials / Completed

CompletedNCT06132269

Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
TCI Co., Ltd. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The AKK formula, a prebiotic blend, can effectively promote the proliferation of A. muciniphila. In this study, we attempt to explore the clinical efficacy of AKK formula for A. muciniphila proliferation and weight management.

Detailed description

This is a double-blind, randomized, parallel and placebo-controlled study. Subjects are informed to consume the samples daily for 8 weeks. The person who is evaluated as obesity by the investigator will be invited to participate in this trial. In this study, we attempt to explore the clinical efficacy of AKK formula for A. muciniphila proliferation and weight management.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAKK formula prebiotic sachet5 g/sachet, containing AKK formula, Indigestible Maltodextrin, Crystalline Maltitol, Calcium Carbonate, Citric Acid, Steviol Glycosides, and flavor. Subjects will consume 1 sachet per day for 8 weeks.
DIETARY_SUPPLEMENTPlacebo sachet5 g/sachet, containing Indigestible Maltodextrin, Crystalline Maltitol, Calcium Carbonate, Citric Acid, Steviol Glycosides, and flavor. Subjects will consume 1 sachet per day for 8 weeks.

Timeline

Start date
2023-11-09
Primary completion
2024-01-30
Completion
2024-05-01
First posted
2023-11-15
Last updated
2024-05-06

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06132269. Inclusion in this directory is not an endorsement.